P3 Health Partners Inc. - Laporan Laba Rugi (TTM)

P3 Health Partners Inc.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi P3 Health Partners Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 491 527 555 582 637 760 884 977 1,049 1,078 1,138 1,178 1,266 1,353 1,403 1,477 1,500 1,485 1,462
Change (%) 7.40 5.26 4.93 9.42 19.18 16.44 10.41 7.47 2.72 5.53 3.52 7.53 6.82 3.70 5.26 1.61 -1.02 -1.57
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 485 516 560 595 659 779 896 989 1,057 1,077 1,112 1,136 1,235 1,331 1,394 1,517 1,559 1,549 1,536
Change (%) 6.43 8.65 6.12 10.89 18.08 15.04 10.43 6.89 1.87 3.23 2.20 8.67 7.81 4.72 8.80 2.80 -0.64 -0.89
% of Revenue 98.66 97.77 100.93 102.08 103.45 102.49 101.26 101.28 100.74 99.90 97.73 96.48 97.50 98.41 99.38 102.72 103.93 104.32 105.04
Gross Operating Profit 7 12 -5 -12 -22 -19 -11 -13 -8 1 26 41 32 22 9 -40 -59 -64 -74
Change (%) 78.93 -143.79 135.53 81.52 -13.88 -41.21 12.35 -37.99 -113.30 2,406.30 60.56 -23.75 -31.85 -59.51 -560.45 46.57 8.91 14.88
% of Revenue 1.34 2.23 -0.93 -2.08 -3.45 -2.49 -1.26 -1.28 -0.74 0.10 2.27 3.52 2.50 1.59 0.62 -2.72 -3.93 -4.32 -5.04
SG&A 55 59 66 72 119 144 167 185 162 162 147 142 126 115 114 113 120 118 114
Change (%) 7.04 11.62 10.53 64.72 20.21 16.55 10.79 -12.40 -0.50 -8.93 -3.58 -11.47 -8.70 -0.92 -0.15 5.88 -2.12 -3.04
% of Revenue 11.18 11.14 11.81 12.45 18.73 18.90 18.92 18.98 15.47 14.99 12.93 12.05 9.92 8.48 8.10 7.68 8.01 7.92 7.80
R&D
Change (%)
% of Revenue
OpEx 520 563 612 654 825 987 1,146 1,270 1,295 1,321 1,341 1,354 1,434 1,516 1,576 1,729 1,819 1,798 1,778
Change (%) 8.31 8.71 6.86 26.23 19.56 16.18 10.81 1.98 1.94 1.51 1.04 5.90 5.68 3.98 9.72 5.21 -1.15 -1.14
% of Revenue 105.82 106.72 110.22 112.25 129.49 129.90 129.61 130.08 123.44 122.51 117.84 115.01 113.26 112.05 112.35 117.11 121.25 121.08 121.61
Operating Income -29 -35 -57 -71 -188 -227 -262 -294 -246 -243 -203 -177 -168 -163 -173 -253 -319 -313 -316
Change (%) 23.99 60.11 25.74 163.36 20.85 15.30 12.18 -16.28 -1.36 -16.36 -12.91 -4.97 -2.97 6.32 45.81 26.20 -1.80 0.89
% of Revenue -5.82 -6.72 -10.22 -12.25 -29.49 -29.90 -29.61 -30.08 -23.44 -22.51 -17.84 -15.01 -13.26 -12.05 -12.35 -17.11 -21.25 -21.08 -21.61
Interest Expense -3 -2 -2 -3 -11 -11 -12 -12 -11 -13 -14 -15 -16 -16 -18 -19 -22 -27 -31
Change (%) -5.40 2.91 8.62 298.51 5.91 2.92 3.73 -5.52 11.67 9.04 7.48 7.10 1.06 9.81 9.27 14.38 20.16 17.68
% of Revenue -0.52 -0.45 -0.44 -0.46 -1.67 -1.49 -1.32 -1.24 -1.09 -1.18 -1.22 -1.27 -1.26 -1.19 -1.26 -1.31 -1.48 -1.79 -2.14
Net Income -31 -49 -74 -90 -156 -142 -267 -246 -270 -269 -124 -126 -58 -67 -69 -103 -136 -138 -146
Change (%) 56.70 51.35 20.60 74.16 -8.99 87.70 -7.81 9.62 -0.51 -53.78 1.71 -54.27 16.45 3.28 47.81 32.29 1.31 6.06
% of Revenue -6.40 -9.33 -13.42 -15.43 -24.55 -18.75 -30.22 -25.23 -25.74 -24.93 -10.92 -10.73 -4.56 -4.97 -4.95 -6.95 -9.05 -9.27 -9.99

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista